{"id":"experimental-arm-a-drl-ri","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Akathisia"},{"rate":"5-10%","effect":"Dystonia"},{"rate":"5-10%","effect":"Parkinsonism"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"5-10%","effect":"Weight gain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by blocking the action of dopamine at D2/D3 receptors in the brain, which may help reduce symptoms of schizophrenia and other psychiatric disorders.","oneSentence":"This drug is a dopamine receptor D2/D3 antagonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:46:41.097Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Schizophrenia"},{"name":"Bipolar disorder"}]},"trialDetails":[{"nctId":"NCT04268771","phase":"PHASE3","title":"A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2020-04-08","conditions":"Rheumatoid Arthritis","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Experimental: Arm A: DRL_RI","genericName":"Experimental: Arm A: DRL_RI","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Biologic","firstApprovalDate":"","aiSummary":"This drug is a dopamine receptor D2/D3 antagonist. Used for Schizophrenia, Bipolar disorder.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}